| 32nd week of 2019 patent applcation highlights part 8 |
| Patent application number | Title | Published |
|---|
| 20190240117 | TWO-PACKAGE DENTAL ADHESIVE COMPOSITION | 2019-08-08 |
| 20190240118 | HYDROPHILIC IMPRESSION MATERIAL WITH IMPROVED STORAGE STABILITY | 2019-08-08 |
| 20190240119 | PROPYL GALLATE-CONTAINING VITAMIN PREPARATIONS | 2019-08-08 |
| 20190240120 | COSMETIC COMPOSITION | 2019-08-08 |
| 20190240121 | CONCENTRATED SHAMPOO DOSAGE OF FOAM FOR PROVIDING HAIR CARE BENEFITS | 2019-08-08 |
| 20190240122 | COSMETIC ANTI-BLEMISH COMPOSITION, USE OF THE COMPOSITION AND ANTI-BLEMISH TREATMENT METHOD | 2019-08-08 |
| 20190240123 | COMPOSITION COMPRISING AT LEAST TWO FATTY ACID ESTERS OF (POLY)GLYCEROL, AND USE THEREOF IN COSMETICS | 2019-08-08 |
| 20190240124 | CORE-COMPOSITE SHELL MICROCAPSULES | 2019-08-08 |
| 20190240125 | COMPOSITION FOR NATURAL SKIN BRIGHTENING EFFECT | 2019-08-08 |
| 20190240126 | TOPICAL COSMETIC COMPOSITION FOR RESTRUCTURING AND PROTECTING HAIR AND SCALP, AND USES THEREOF | 2019-08-08 |
| 20190240127 | COSMETIC ANTI-BLEMISH COMPOSITION, USE OF THE COMPOSITION AND METHOD FOR ANTI-BLEMISH TREATMENT | 2019-08-08 |
| 20190240128 | COMPOSITION FOR TREATING KERATIN FIBERS COMPRISING AN AMPHOTERIC OR CATIONIC POLYMER AND NEUTRALIZED FATTY ACID | 2019-08-08 |
| 20190240129 | CONDITIONING HAIR TREATMENT PRODUCT WITH WASHOUT PROTECTION | 2019-08-08 |
| 20190240130 | HAIR COSMETIC COMPOSITION COMPRISING THIOL-BASED COMPOUNDS | 2019-08-08 |
| 20190240131 | AQUEOUS SURFACTANT COMPOSITIONS | 2019-08-08 |
| 20190240132 | Skin care combination | 2019-08-08 |
| 20190240133 | HAIR COLORING COMPOSITIONS AND METHODS THEREOF | 2019-08-08 |
| 20190240134 | A SKINCARE COSMETIC COMPOSITION | 2019-08-08 |
| 20190240135 | METHODS FOR ADMINISTRATION OF COSMETIC AND MEDICAL AGENTS | 2019-08-08 |
| 20190240136 | COMPOSITION | 2019-08-08 |
| 20190240137 | USE OF CATIONIC POLYMER HAVING QUATERNARY AMMONIUM GROUPS FOR THE PROTECTION OF HAIR AGAINST UV DAMAGE | 2019-08-08 |
| 20190240138 | DISPERSION OF DROPS OF A FIRST PHASE, DISPERSED IN A SECOND PHASE SUBSTANTIALLY IMMISCIBLE WITH THE FIRST PHASE | 2019-08-08 |
| 20190240139 | TOPICAL COMPOSITIONS | 2019-08-08 |
| 20190240140 | Face and body cream composition | 2019-08-08 |
| 20190240141 | REDNESS CORRECTING SKIN CARE FORMULATIONS | 2019-08-08 |
| 20190240142 | HAIR GROWTH-PROMOTING COMPOSITION AND METHOD FOR PROMOTING HAIR GROWTH | 2019-08-08 |
| 20190240143 | Sustained Release Pharmaceutical Dosage Form of Entecavir | 2019-08-08 |
| 20190240144 | EFFERVESCENT DEFERIPRONE TABLET | 2019-08-08 |
| 20190240145 | EXTENDED RELEASE OF NEUREGULIN FOR TREATING HEART FAILURE | 2019-08-08 |
| 20190240146 | ADENOVIRUS FORMULATIONS | 2019-08-08 |
| 20190240147 | POLYMERIC COMPOSITIONS CONTAINING AMBIENT-TEMPERATURE STABLE BIOPHARMACEUTICALS & METHODS FOR FORMULATION THEREOF | 2019-08-08 |
| 20190240148 | LUBRICANT COMPOSITION AND METHOD FOR PREPARING THE COMPOSITION | 2019-08-08 |
| 20190240149 | PHARMACEUTICAL COMPOSITIONS COMPRISING SILICA MICROSPHERES | 2019-08-08 |
| 20190240150 | INTRANASAL DELIVERY OF OLANZAPINE BY PRECISION OLFACTORY DEVICE | 2019-08-08 |
| 20190240151 | VASOCONSTRICTION COMPOSITIONS AND METHODS OF USE | 2019-08-08 |
| 20190240152 | CONTACT LENS COMPOSITIONS AND METHODS FOR THE TREATMENT OF PRESBYOPIA | 2019-08-08 |
| 20190240153 | Antimicrobial Polymer for Use in Ophthalmic implants | 2019-08-08 |
| 20190240154 | MODIFIED HYALURONIC ACID HYDROGELS AND PROTEINS FOR THE TIME-CONTROLLED RELEASE OF BIOLOGIC AGENTS | 2019-08-08 |
| 20190240155 | LIQUID FORMULATIONS OF DAPTOMYCIN | 2019-08-08 |
| 20190240156 | Therapeutic Compositions Comprising Mesenchymal Stem Cell Particles And Related Methods | 2019-08-08 |
| 20190240157 | PHARMACEUTICAL COMPOSITION COMPRISING AMORPHOUS LENALIDOMIDE AND AN ANTIOXIDANT | 2019-08-08 |
| 20190240158 | IMMEDIATE RELEASE TABLET OF DOFETILIDE | 2019-08-08 |
| 20190240159 | COMPOSITIONS COMPRISING PGI2-RECEPTOR AGONISTS AND PROCESSES FOR THE PREPARATION THEREOF | 2019-08-08 |
| 20190240160 | ACID RESISTANT CAPSULES | 2019-08-08 |
| 20190240161 | CERIA NANOCOMPOSITE COMPRISING CERIA NANOPARTICLE FOR TREATING SUBARACHNOID HEMORRHAGE, METHOD FOR PREPARING SAME, AND PHARMACEUTICAL COMPOSITION | 2019-08-08 |
| 20190240162 | VACCINE DELIVERY SYSTEMS USING YEAST CELL WALL PARTICLES | 2019-08-08 |
| 20190240163 | MULTIPARTICULATE INCLUDING PHARMACEUTICAL OR PROBIOTIC ACTIVE INGREDIENTS FOR DELIVERY VIA A SHELF STABLE LIQUID DOSAGE FORM | 2019-08-08 |
| 20190240164 | Delivery Compositions, and Methods of Making and Using Same | 2019-08-08 |
| 20190240165 | HAIR GROWTH STIMULATING DRESSING | 2019-08-08 |
| 20190240166 | Transdermal Therapeutic System for 5-Aminolevulinic Acid Hydrochloride | 2019-08-08 |
| 20190240167 | TWO-LAYER TOPICAL THERAPEUTIC SYSTEM | 2019-08-08 |
| 20190240168 | METHOD FOR INCREASING AKKERMANSIA IN INTESTINAL BACTERIAL FLORA BY INGESTING ASTAXANTHIN | 2019-08-08 |
| 20190240169 | PHARMACEUTICAL COMPOSITIONS AND METHODS UTILIZING A D-AMINO ACID | 2019-08-08 |
| 20190240170 | Use of Scavengers of Reactive Gamma-Ketoaldehydes to Extend Cell Lifespan and Healthspan | 2019-08-08 |
| 20190240171 | PREVENTIVE AND THERAPEUTIC APPROACH FOR ABERRANT CELL DIFFERENTIATION AND ISR-ASSOCIATED DISEASES | 2019-08-08 |
| 20190240172 | PHARMACEUTICAL COMPOSITION FOR PREVENTING OR TREATING DIABETES AND/OR HYPERLIPIDEMIA COMPRISING MIDODRINE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF AS ACTIVE INGREDIENT | 2019-08-08 |
| 20190240173 | NEW USE OF N,N-BIS-2-MERCAPTOETHYL ISOPHTHALAMIDE | 2019-08-08 |
| 20190240174 | USE OF (1S,3S)-3-AMINO-4-(DIFLUOROMETHYLIDENE) CYCLOPENTANE-1-CARBOXYLIC ACID AND (S)-3-AMINO-4-(DIFLUOROMETHYLENYL)CYCLOPENT-1-ENE-1-CARBOXYLIC ACID IN THE TREATMENT OF TINNITUS, ACUTE SENSORINEURAL HEARING LOSS, MENIERE'S DISEASE, TOURETTE'S SYNDROME, ATTENTION DEFICIT HYPERACTIVITY DISORDER AND ADDICTION | 2019-08-08 |
| 20190240175 | TREATMENT OF OSTEOARTHRITIS | 2019-08-08 |
| 20190240176 | METHODS OF TREATMENT FOR MYELOID LEUKEMIA | 2019-08-08 |
| 20190240177 | SUBSTITUTED BISPHENYL BUTANOIC ESTER DERIVATIVES AS NEP INHIBITORS | 2019-08-08 |
| 20190240178 | NOVEL COMPOSITION FOR IMPROVED SLEEP | 2019-08-08 |
| 20190240179 | TREATMENT OF NERVOUS SYSTEM DISORDERS USING COMBINATIONS OF RXR AGONISTS AND THYROID HORMONES | 2019-08-08 |
| 20190240180 | MCT-BASED NUTRITION BLEND FOR PROVIDING HEALTH BENEFITS IN COMPANION ANIMALS | 2019-08-08 |
| 20190240181 | Compositions for Diagnosis and Treatment of Inflammation | 2019-08-08 |
| 20190240182 | METHODS OF TREATING MIXED DYSLIPIDEMIA | 2019-08-08 |
| 20190240183 | COMPOSITIONS AND METHODS FOR LOWERING LEVELS OF HIGH-SENSITIVITY (HS-CRP) IN A SUBJECT | 2019-08-08 |
| 20190240184 | PHARMACEUTICAL APPLICATIONS FOR (S)-NORKETAMINE AND SALTS THEREOF | 2019-08-08 |
| 20190240185 | TREATMENT WITH ANTI ErbB2 ANTIBODIES | 2019-08-08 |
| 20190240186 | GOLD NANOPARTICLE BASED FORMULATION FOR USE IN CANCER THERAPY | 2019-08-08 |
| 20190240187 | ORAL PREPARATIONS WITH OMEPRAZOLE OR PANTOPRAZOLE | 2019-08-08 |
| 20190240188 | SMALL MOLECULES AGAINST CANCER | 2019-08-08 |
| 20190240189 | TUMESCENT INFILTRATION DRUG DELIVERY OF CANNABINOIDS | 2019-08-08 |
| 20190240191 | Terpene-Based Compositions, Processes Methodologies | 2019-08-08 |
| 20190240192 | COMPOSITION AND APPARATUS FOR TREATMENT OF CHEMOTHERAPY INDUCED ALOPECIA | 2019-08-08 |
| 20190240193 | COMPOSITIONS COMPRISING CROMOGLICIC ACID FOR THE TREATMENT OF DERMATITIS | 2019-08-08 |
| 20190240194 | MACROPHAGES/MICROGLIA IN NEURO-INFLAMMATION ASSOCIATED WITH NEURODEGENERATIVE DISEASES | 2019-08-08 |
| 20190240195 | METHODS OF TREATING MUSCULAR DYSTROPHY | 2019-08-08 |
| 20190240196 | LACTAMS FOR USE IN THE TREATMENT OF SKIN LESIONS | 2019-08-08 |
| 20190240197 | PHARMACEUTICAL COMPOSITIONS FOR TREATING CYSTIC FIBROSIS | 2019-08-08 |
| 20190240198 | FORMULATIONS AND METHODS FOR THE TREATMENT OF CANCERS | 2019-08-08 |
| 20190240199 | TREATMENT FOR GLIOBLASTOMA | 2019-08-08 |
| 20190240200 | PHARMACEUTICAL COMPOSITIONS COMPRISING 4-[1-(2,3-DIMETHYLPHENYL)ETHYL]-3H-IMIDAZOLE DERIVATIVES FOR TREATING RETINAL DISEASES | 2019-08-08 |
| 20190240201 | OCULAR FORMULATIONS FOR DRUG-DELIVERY TO THE POSTERIOR SEGMENT OF THE EYE | 2019-08-08 |
| 20190240202 | Methods and Compositions for Re-activating Epstein-Barr Virus and Screening Compounds Therefor | 2019-08-08 |
| 20190240203 | NOVEL ANTIBIOTICS AND METHODS OF USING SAME | 2019-08-08 |
| 20190240204 | DEUTERATED COMPOUNDS AND MEDICAL USES THEREOF | 2019-08-08 |
| 20190240205 | FORMULATIONS AND METHODS OF MANUFACTURING FORMULATIONS FOR USE IN COLONIC EVACUATION | 2019-08-08 |
| 20190240206 | SUSTAINED RELEASE AMINOPYRIDINE COMPOSITION | 2019-08-08 |
| 20190240207 | METHOD FOR TREATING CANCER WITH DIHYDROPYRIDINE CALCIUM ANTAGONIST | 2019-08-08 |
| 20190240208 | METHODS AND DEVICES FOR THE TREATMENT OF OCULAR DISEASES IN HUMAN SUBJECTS | 2019-08-08 |
| 20190240209 | FORMULATION HAVING IMPROVED PH-DEPENDENT DRUG- RELEASE CHARACTERISTICS, CONTAINING ESOMEPRAZOLE OR PHARMACEUTICALLY ACCEPTABLE SALT THEREOF | 2019-08-08 |
| 20190240210 | Treatment Method by Combined Use of MDM2 Inhibitor and DNA Methyltransferase Inhibitor | 2019-08-08 |
| 20190240211 | COMBINATION OF PIMAVANSERIN AND CYTOCHROME P450 MODULATORS | 2019-08-08 |
| 20190240212 | METHODS OF TREATING RBP4 RELATED DISEASES WITH TRIAZOLOPYRIDINES | 2019-08-08 |
| 20190240213 | NOVEL NITROGEN-CONTAINING HETEROARYL COMPOUNDS AND METHODS OF USE THEREOF | 2019-08-08 |
| 20190240214 | ABUSE-RESISTANT MUCOADHESIVE DEVICES FOR DELIVERY OF BUPRENORPHINE | 2019-08-08 |
| 20190240215 | TABLET COMPRISING 7-[4-(4-BENZO[B]THIOPHEN-4-YL-PIPERAZIN-1-YL)BUTOXY]-1H-QUINOLIN-2-ONE OR A SALT THEREOF | 2019-08-08 |
| 20190240216 | AZOLE PHARMACEUTICAL FORMULATIONS FOR PARENTERAL ADMINISTRATION AND METHODS FOR PREPARING AND USING THE SAME AS TREATMENT OF DISEASES SENSITIVE TO AZOLE COMPOUNDS | 2019-08-08 |
| 20190240217 | POLYCYCLIC-CARBAMOYLPYRIDONE COMPOUNDS AND THEIR PHARMACEUTICAL USE | 2019-08-08 |
